Hypoxia-inducible factor 1 alpha (HIF-1α) gene expression in human ovarian carcinoma

Cancer Letters

Volumn 176, Issue 2, 2002, Pages 215-223

  Nakayama, Kentaro ^a,b   Kanzaki, Atsuko ^a   Hata, Kohkichi ^b   Katabuchi, Hidetaka ^c   Okamura, Hitoshi ^c   Miyazaki, Kohji ^b   Fukumoto, Manabu ^a   Takebayashi, Yuji ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Hypoxia inducible factor 1 alpha; Intratumoral microvessel density; Ovarian carcinoma; Vascular endothelial cell growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCLONAL ANTIBODY; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; OVARY CARCINOMA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; ANTIGENS, CD34; CARCINOMA; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037169870     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00762-5     Document Type: Article

References (45)

1. Induction of angiogenesis during the transition from hyperplasia to neoplasia
2. Tumor invasion and metastasis: An imbalance of positive and negative regulation
3. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
4. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
5. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
6. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
7. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
8. Angiostatin induces and sustains dormancy of human primary tumors in mice
9. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth
10. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
11. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
12. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
13. Oncogenic alterations of metabolism
14. The hypoxic response: Huffing and HIFing
15. 2 homeostasis by hypoxia-inducible factor 1
16. 2 tension
17. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation
18. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes
19. 2-dependent degradation domain via the ubiquitin-proteasome pathway
20. Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway
21. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha
22. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
23. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
24. Vascular endothelial growth factor in human colon cancer: Biology and therapeutic implications
25. Prognostic value of vascular endothelial growth factor in breast cancer
26. Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
27. Overexpression of hypoxia-inducible factor 1alpha is a marker for an unfavorable prognosis in early-stage invasive cervical cancer
28. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics
29. Morphogenesis of uterine myomas
30. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas
31. Tumor angiogenesis in advanced stage ovarian carcinoma
32. Differences in the angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density
33. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: Quantification of endothelial immunoreactivity by image analysis
34. Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary
35. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer
36. Angiogenesis in early-invasive and low-malignant-potential epithelial ovarian carcinoma
37. Expression of thymidine phosphorylase in epithelial ovarian cancer: Correlation with angiogenesis, apoptosis, and ultrasound-derived peak systolic velocity
38. The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer
39. Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas
40. VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary
41. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
42. Different features of angiogenesis between ovarian and breast carcinoma
43. Potential role of the inactivated X chromosome in ovarian epithelial tumor development
44. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue
45. Analysis of gene amplification and overexpression in human esophageal- carcinoma cell lines